Wir bieten KI-basierte Softwarelösungen
als zertifizierte Medizinprodukte zur Vorhersage
postoperativer Komplikationen
Operational phase
x-cardiac-platform
The x-cardiac-platform is an AI software as a medical device based on the latest interoperability standards and a scalable prediction plug-in mechanism.
Software Products
Derzeit umfasst das Portfolio von x-cardiac Softwareprodukte zur Vorhersage von postoperativen
Blutungen, die eine Revision erfordern, und akutem postoperativem Nierenversagen.
Das Team von x-cardiac arbeitet derzeit an der Erweiterung des Spektrums um
Vorhersagealgorithmen für hämodynamische Instabilität und andere Komplikationen.
x-c-bleeding™: Ein digitaler Biomarker zur Vorhersage von postoperativen Blutungen, die eine Revision erfordern, was es den
medizinischen Fachkräften ermöglicht, frühzeitig geeignete Gegenmaßnahmen einzuleiten.
​
The challenges addressed by x-cardiac:
postoperative bleeding
A complication with a high need for preventive solutions
For patients High incidence: Rethoracotomy due to postoperative bleeding, incidence 5.82% 1 High mortality in case of bleeding - up to 4-fold increase to up to 12 %2 Longer ITS stay: for bleeding from 4 to 6.4 days3
For medical personnel text text text
For hospital management text text
Pioneer in the digital age of health care by introducing x-cardiac to your hospital or your clients
Succesful Integration of
Fine-Tuning into QM and Regulatory Systems
Patient Safety and Algorithm Adjustment:
​
-
Necessary to adapt algorithms to specific clinical settings for enhanced patient safety
-
General consensus on the inevitability of adjustments due to inherent AI product challenges.
Regulatory Constraints on Product Changes:
​
-
Medical products cannot be arbitrarily modified.
-
Described the process as 'Site-Specific Model Optimization' (Optional). Considered more of a configuration rather than a significant modification.
QM Technical Consideration:
​
-
Fine-tuning does not alter the core algorithm.
-
No change to input or output, merely additional training epochs.
Why choose x-cardiac?
Placing your trust in digitalization pays off, even more, when you choose x-cardiac as your partner. Our products for clinical decision support can be implemented without the need for large-scale IT projects. They also enhance your existing system with useful new functions.
x-c-bleeding is clinically validated
x-cardiac’s solutions are based on more than four years of research, developed with around 50.000 patient data sets, clinically validated in a study with 10.000 patients published in The Lancet Respiratory Medicine.